Literature DB >> 17404625

Acceptance of the 2006 Kober medal.

David G Nathan1.   

Abstract

Mesh：

Year:  2007        PMID： 17404625      PMCID： PMC1839813          DOI： 10.1172/JCI32146

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  10 in total

1.  The National Institutes of Health and clinical research: a progress report.

Authors:  D G Nathan; H E Varmus
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

2.  Acceptance of the Kober medal award for 1962 (W.B. CASTLE).

Authors:  W B CASTLE
Journal:  Trans Assoc Am Physicians       Date:  1962

3.  The several Cs of translational clinical research.

Authors:  David G Nathan
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

4.  NIH support for basic and clinical research: biomedical researcher angst in 2006.

Authors:  David G Nathan; Alan N Schechter
Journal:  JAMA       Date:  2006-06-14       Impact factor: 56.272

5.  The NIH budget and the future of biomedical research.

Authors:  Joseph Loscalzo
Journal:  N Engl J Med       Date:  2006-04-20       Impact factor: 91.245

6.  US biomedical research under siege.

Authors:  Paul Nurse
Journal:  Cell       Date:  2006-01-13       Impact factor: 41.582

7.  Outcomes of National Institutes of Health peer review of clinical grant applications.

Authors:  Theodore A Kotchen; Teresa Lindquist; Anita Miller Sostek; Raymond Hoffmann; Karl Malik; Brent Stanfield
Journal:  J Investig Med       Date:  2006-01       Impact factor: 2.895

Review 8.  The clinical investigator: bewitched, bothered, and bewildered--but still beloved.

Authors:  J L Goldstein; M S Brown
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

9.  Clinical research: perceptions, reality, and proposed solutions. National Institutes of Health Director's Panel on Clinical Research.

Authors:  D G Nathan
Journal:  JAMA       Date:  1998-10-28       Impact factor: 56.272

10.  Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial.

Authors:  Eric Nisbet-Brown; Nancy F Olivieri; Patricia J Giardina; Robert W Grady; Ellis J Neufeld; Romain Séchaud; Axel J Krebs-Brown; Judith R Anderson; Daniele Alberti; Kurt C Sizer; David G Nathan
Journal:  Lancet       Date:  2003-05-10       Impact factor: 79.321
  10 in total
  1 in total

Review 1.  A history of the American Society for Clinical Investigation.

Authors:  Joel D Howell
Journal:  J Clin Invest       Date:  2009-04       Impact factor: 14.808
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.